The Top 5 Milestone Cases That Put Steve Mostyn’s Texas Law Firm on the Map
As a trial lawyer, Steve Mostyn and Mostyn Law, the Texas firm he and his wife Amber run, have presided over some of the most successful cases stemming from major…
As a trial lawyer, Steve Mostyn and Mostyn Law, the Texas firm he and his wife Amber run, have presided over some of the most successful cases stemming from major…
What do the Hells Angels, the Latin Kings, and the Gambino crime family have in common? They’ve all been charged by federal prosecutors under the Racketeer Influenced and Corrupt Organizations…
Of the two pathways available to medical device manufacturers seeking FDA approval for new products, the 510(k) process is the cheaper and significantly faster route. But, how safe is it?…
With so much whining from the pharmaceutical and medical device industries over the onerous process of Federal Drug Administration (FDA) approval for a new treatment or technology, one would assume…
The U.S. Food and Drug Administration (FDA) first approved transvaginal mesh for surgical use in 1996 as a minimally invasive treatment option for women suffering from pelvic floor disorders, like…
In the video below, Attorney Steve Mostyn discusses the disturbing allegations made against American medical device manufacturer, Boston Scientific, and how the company allegedly engaged in an international conspiracy to…
Of the sixty or so pelvic meshes that were or currently are on the market in the United States you may not have heard of the ProteGen mesh, a model…
In a move that could be considered too little and too late – Boston Scientific is updating the warning on its pelvic mesh products. Boston Scientific, based in Marlborough Mass.,…
This is part two of a multi-part series uncovering common myths related to pelvic mesh. Myth Busters Part One can be found here while Myth Busters Part Three can be…
This is part one of a multi-part series uncovering common myths related to pelvic mesh. Myth Busters Part Two can be found here while Myth Busters Part Three can be…